| Literature DB >> 29363062 |
Julijana Ivanisevic1, Aurelien Thomas2,3.
Abstract
Multiple diseases have a strong metabolic component, and metabolomics as a powerful phenotyping technology, in combination with orthogonal biological and clinical approaches, will undoubtedly play a determinant role in accelerating the understanding of mechanisms that underlie these complex diseases determined by a set of genetic, lifestyle, and environmental exposure factors. Here, we provide several examples of valuable findings from metabolomics-led studies in diabetes and obesity metabolism, neurodegenerative disorders, and cancer metabolism and offer a longer term vision toward personalized approach to medicine, from population-based studies to pharmacometabolomics.Entities:
Keywords: Cancer metabolism; Diabetes metabolism; Metabolomics; Neurodegenerative diseases; Obesity metabolism; Personalized medicine; Pharmacometabolomics; Population studies
Mesh:
Substances:
Year: 2018 PMID: 29363062 DOI: 10.1007/978-1-4939-7592-1_1
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745